ARAC signs a distribution agreement with SANOFI:

04/04/2012 Argaam

SPIMACO Pharmaceutical Company announced today on tadawul signing 5 years renewable agreement with SANOFI to manufacture and distribute the Doanil M Diabetes medication.

Doanil M is to be manufactured in SPIMACO’s medical plant in Qassim and to be distributed by ARAC (a wholly owned sub of SPIMACO).

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.